XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.3
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
shares in Thousands, $ in Millions
Total
Common Stock
Paid-In Capital
Treasury Stock At Cost
Accumulated Other Comprehensive Loss
Retained Earnings
Beginning balance (in shares) at Jan. 30, 2022   61,560        
Beginning balance at Jan. 30, 2022 $ 275.5 $ 0.6 $ 548.8 $ (605.4) $ (3.6) $ 335.1
Beginning balance (in shares) at Jan. 30, 2022       13,070    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 67.0         67.0
Derivatives, net of tax 1.3       1.3  
Share-based compensation 3.6   3.6      
Issuance of common stock (in shares)   250        
Issuance of common stock 5.6   5.6      
Repurchase of common stock (in shares)       30    
Repurchase of common stock (1.2)     $ (1.2)    
Ending balance (in shares) at May. 01, 2022   61,810        
Ending balance at May. 01, 2022 351.8 $ 0.6 558.0 $ (606.6) (2.3) 402.1
Ending balance (in shares) at May. 01, 2022       13,100    
Beginning balance (in shares) at Jan. 30, 2022   61,560        
Beginning balance at Jan. 30, 2022 275.5 $ 0.6 548.8 $ (605.4) (3.6) 335.1
Beginning balance (in shares) at Jan. 30, 2022       13,070    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 98.0          
Unrealized foreign currency translation gain (loss) (0.4)          
Derivatives, net of tax 3.0          
Ending balance (in shares) at Oct. 30, 2022   62,280        
Ending balance at Oct. 30, 2022 361.0 $ 0.6 566.2 $ (637.9) (1.0) 433.1
Ending balance (in shares) at Oct. 30, 2022       14,000    
Beginning balance (in shares) at May. 01, 2022   61,810        
Beginning balance at May. 01, 2022 351.8 $ 0.6 558.0 $ (606.6) (2.3) 402.1
Beginning balance (in shares) at May. 01, 2022       13,100    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 29.1         29.1
Derivatives, net of tax 1.4       1.4  
Share-based compensation 4.7   4.7      
Issuance of common stock (in shares)   400        
Repurchase of common stock (in shares)       890    
Repurchase of common stock (30.6)     $ (30.6)    
Ending balance (in shares) at Jul. 31, 2022   62,210        
Ending balance at Jul. 31, 2022 356.4 $ 0.6 562.7 $ (637.2) (0.9) 431.2
Ending balance (in shares) at Jul. 31, 2022       13,990    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 1.9         1.9
Unrealized foreign currency translation gain (loss) (0.4)       (0.4)  
Derivatives, net of tax 0.3       0.3  
Share-based compensation 3.2   3.2      
Issuance of common stock (in shares)   70        
Issuance of common stock 0.3   0.3      
Repurchase of common stock (in shares)       10    
Repurchase of common stock (0.7)     $ (0.7)    
Ending balance (in shares) at Oct. 30, 2022   62,280        
Ending balance at Oct. 30, 2022 $ 361.0 $ 0.6 566.2 $ (637.9) (1.0) 433.1
Ending balance (in shares) at Oct. 30, 2022       14,000    
Beginning balance (in shares) at Jan. 29, 2023 48,410 62,420        
Beginning balance at Jan. 29, 2023 $ 410.5 $ 0.6 577.5 $ (639.0) (0.9) 472.3
Beginning balance (in shares) at Jan. 29, 2023 14,010     14,010    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) $ 70.1         70.1
Share-based compensation 6.7   6.7      
Issuance of common stock (in shares)   90        
Issuance of common stock 0.1   0.1      
Repurchase of common stock (in shares)       3,620    
Repurchase of common stock (127.5)     $ (127.5)    
Ending balance (in shares) at Apr. 30, 2023   62,510        
Ending balance at Apr. 30, 2023 $ 359.9 $ 0.6 584.3 $ (766.5) (0.9) 542.4
Ending balance (in shares) at Apr. 30, 2023       17,630    
Beginning balance (in shares) at Jan. 29, 2023 48,410 62,420        
Beginning balance at Jan. 29, 2023 $ 410.5 $ 0.6 577.5 $ (639.0) (0.9) 472.3
Beginning balance (in shares) at Jan. 29, 2023 14,010     14,010    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) $ 90.8          
Unrealized foreign currency translation gain (loss) (0.2)          
Derivatives, net of tax $ 0.0          
Ending balance (in shares) at Oct. 29, 2023 40,190 62,720        
Ending balance at Oct. 29, 2023 $ 211.6 $ 0.6 593.8 $ (944.8) (1.1) 563.1
Ending balance (in shares) at Oct. 29, 2023 22,530     22,530    
Beginning balance (in shares) at Apr. 30, 2023   62,510        
Beginning balance at Apr. 30, 2023 $ 359.9 $ 0.6 584.3 $ (766.5) (0.9) 542.4
Beginning balance (in shares) at Apr. 30, 2023       17,630    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 25.9         25.9
Unrealized foreign currency translation gain (loss) 0.1       0.1  
Share-based compensation 5.2   5.2      
Issuance of common stock (in shares)   180        
Issuance of common stock 0.6   0.6      
Repurchase of common stock (in shares)       2,090    
Repurchase of common stock (77.3)     $ (77.3)    
Ending balance (in shares) at Jul. 30, 2023   62,690        
Ending balance at Jul. 30, 2023 314.4 $ 0.6 590.1 $ (843.8) (0.8) 568.3
Ending balance (in shares) at Jul. 30, 2023       19,720    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (5.2)         (5.2)
Unrealized foreign currency translation gain (loss) (0.3)       (0.3)  
Derivatives, net of tax 0.0          
Share-based compensation 3.5   3.5      
Issuance of common stock (in shares)   30        
Issuance of common stock 0.2   0.2      
Repurchase of common stock (in shares)       2,810    
Repurchase of common stock $ (101.0)     $ (101.0)    
Ending balance (in shares) at Oct. 29, 2023 40,190 62,720        
Ending balance at Oct. 29, 2023 $ 211.6 $ 0.6 $ 593.8 $ (944.8) $ (1.1) $ 563.1
Ending balance (in shares) at Oct. 29, 2023 22,530     22,530